Skip to content

Osteoporosis Disease Management Demonstration Project (0000-037)

Osteoporosis Prevention and Treatment Program: A Disease Management Demonstration Project

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00139425
Enrollment
10000
Registered
2005-08-31
Start date
2003-05-31
Completion date
2004-12-31
Last updated
2016-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Brief summary

The purpose of this study is to assess the impact of disease management interventions on bone mineral density (BMD) screening rates and osteoporosis treatment rates in women age 65 years or older.

Interventions

Sponsors

Merck Sharp & Dohme LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
65 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Members of the Henry Ford Health System

Exclusion criteria

* Individuals who are not members of the Henry Ford Health System

Design outcomes

Primary

MeasureTime frame
Bone mineral density (BMD) testing rates

Secondary

MeasureTime frame
Osteoporosis medication treatment rates

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 7, 2026